Lupin Ltd (LUPN.NS)
15 Dec 2017
Thu, Dec 14 2017
* SAYS LUPIN RECEIVES FDA APPROVAL FOR GENERIC SAFYRAL TABLETS
Nov 17 Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange's 30-member Sensex index, effective Dec. 18, the index provider said on Friday.
* Says co launches generic Acticlate tablets in U.S. Source text: http://bit.ly/2ypyZzY Further company coverage:
* U.S. sales down 32 pct (Recasts, adds details, bullets, share moves)
* Says as expected, co continues to see pricing pressure for its U.S. generic business
Oct 30 Indian drugmaker Lupin Ltd on Monday said its second-quarter profit fell about 31 percent, but the results were slightly above estimates.
* Sept quarter consol net profit 4.55 billion rupees versus profit of 6.62 billion rupees last year
* Says Lupin receives FDA approval for generic Kapvay extended-release tablets
* Says gets FDA nod for generic Axirona topical solution Source text: http://bit.ly/2xmz2rG Further company coverage:
* Says gets U.S. FDA approval for carbidopa tablets, 25 mg Source text - http://bit.ly/2z3pjeB Further company coverage: